Esperion Therapeutics just released some news that has investors celebrating and its share price soaring. The small biotech company has a medicine called bempadoic acid, which is intended to be used as an adjunct to statin therapy in patients with hypercholesterolemia. This is a state of high levels of cholesterol in the blood. Adjunct therapy … Continue reading “Esperion Therapeutics Shares Explode After This FDA News”
Tag: cholesterol drug
Biotech & Pharma
Pfizer (PFE) Just Ditched Its High-Profile Cholesterol Drug
Shares of Pfizer dropped about 2% after the pharma giant decided to scrap its high-profile…
November 1, 2016